Eledon Pharmaceuticals, Inc.
Develops immunomodulatory therapies to prevent organ rejection in transplant patients.
ELDN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 19800 MACARTHUR BLVD., 92612 IRVINE
- Website:
- https://eledon.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Eledon Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing immunomodulatory therapies for organ and cell transplantation. The company's mission, "One Transplant for Life," centers on improving organ longevity and recipient quality of life. Its lead compound, tegoprubart, is an anti-CD40L antibody designed to regulate the immune system and prevent the rejection of transplanted organs. By targeting the CD40 Ligand pathway, Eledon aims to provide a significant advancement over current immunosuppressive treatments. Tegoprubart is in clinical development for kidney transplant recipients, with its potential also being evaluated for other applications, including liver transplantation and xenotransplantation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Eledon Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Eledon Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Eledon Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
